Quinupristin/dalfopristin and voriconazole controlled Staphylococcus epidermidis pneumonia and chronic necrotizing aspergillosis in a patient with severe lung degradation consequent to multiple treatments for Hodgkin's lymphoma

Search this Article

Author(s)

    • MUTO Hideharu
    • Department of Clinical and Experimental Hematology, Doctoral Program in Advanced Biomedical Applications, Graduate School of Comprehensive Human Sciences, University of Tsukuba
    • KANEKO Shin
    • Department of Clinical and Experimental Hematology, Doctoral Program in Advanced Biomedical Applications, Graduate School of Comprehensive Human Sciences, University of Tsukuba
    • MACHINO Takayuki
    • Department of Clinical and Experimental Hematology, Doctoral Program in Advanced Biomedical Applications, Graduate School of Comprehensive Human Sciences, University of Tsukuba
    • OKOSHI Yasushi
    • Department of Clinical and Experimental Hematology, Doctoral Program in Advanced Biomedical Applications, Graduate School of Comprehensive Human Sciences, University of Tsukuba
    • MUKAI Harumi Y.
    • Department of Clinical and Experimental Hematology, Doctoral Program in Advanced Biomedical Applications, Graduate School of Comprehensive Human Sciences, University of Tsukuba
    • SUZUKAWA Kazumi
    • Department of Laboratory Medicine, Doctoral Programs in Medical Sciences, Graduate School of Comprehensive Human Sciences, University of Tsukuba
    • HASEGAWA Yuichi
    • Department of Clinical and Experimental Hematology, Doctoral Program in Advanced Biomedical Applications, Graduate School of Comprehensive Human Sciences, University of Tsukuba
    • IMAGAWA Shigehiko
    • Department of Clinical and Experimental Hematology, Doctoral Program in Advanced Biomedical Applications, Graduate School of Comprehensive Human Sciences, University of Tsukuba
    • KOJIMA Hiroshi
    • Department of Clinical and Experimental Hematology, Doctoral Program in Advanced Biomedical Applications, Graduate School of Comprehensive Human Sciences, University of Tsukuba
    • ISHII Yukio
    • Department of Respiratory Medicine, Doctoral Programs in Medical Sciences, Graduate School of Comprehensive Human Sciences, University of Tsukuba
    • HITOMI Shigemi
    • Department of Infectious Diseases, Doctoral Programs in Medical Sciences, Graduate School of Comprehensive Human Sciences, University of Tsukuba
    • NAGASAWA Toshiro
    • Department of Clinical and Experimental Hematology, Doctoral Program in Advanced Biomedical Applications, Graduate School of Comprehensive Human Sciences, University of Tsukuba

Journal

  • Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy

    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 12(6), 391-395, 2006-12-01

References:  12

Codes

  • NII Article ID (NAID)
    10018697318
  • NII NACSIS-CAT ID (NCID)
    AA11057978
  • Text Lang
    ENG
  • Article Type
    NOT
  • ISSN
    1341321X
  • Data Source
    CJP 
Page Top